Olema Pharmaceuticals, Inc.OLMANASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
4.15%
↑ 117% above average
Average (23q)
-24.21%
Historical baseline
Range
High:30.25%
Low:-216.49%
Volatility
-1019.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 4.15% |
| Q2 2025 | -37.25% |
| Q1 2025 | 5.15% |
| Q4 2024 | 2.27% |
| Q3 2024 | -12.20% |
| Q2 2024 | 2.36% |
| Q1 2024 | -12.90% |
| Q4 2023 | -30.31% |
| Q3 2023 | -8.06% |
| Q2 2023 | 27.03% |
| Q1 2023 | -8.75% |
| Q4 2022 | -17.21% |
| Q3 2022 | 30.25% |
| Q2 2022 | -43.17% |
| Q1 2022 | -6.88% |
| Q4 2021 | -22.49% |
| Q3 2021 | -7.51% |
| Q2 2021 | -6.94% |
| Q1 2021 | -52.50% |
| Q4 2020 | -28.76% |
| Q3 2020 | -216.49% |
| Q2 2020 | -138.35% |
| Q1 2020 | -2.56% |
| Q4 2019 | 0.00% |